What's new in colorectal cancer screening?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 5, 1998, Pages 528-533

  Frommer, D J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Colonoscopy; Colorectal cancer; Faecal occult blood testing; Mortality; Screening; Sigmoidoscopy; Trials

Indexed keywords

BARIUM;

ADULT; BARIUM ENEMA; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY;

EID: 0031808465     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00681.x     Document Type: Review

References (29)

1. Hardeastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer by faecal-occult-blood test. Lancet 1996; 348: 1467-71.
3. Burt RW, Petersen GM. Familial colorectal cancer: Diagnosis and management. In: Young GP, Rozen P, Levin B, eds. Prevention and Early Detection of Colorectal Cancer, London: Saunders, 1996; 171-94.
4. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Spezer RD, Willet WC. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med. 1994; 331: 1669-74.
5. St. John DJB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ESR. Cancer risk in relatives of patients with common colorectal cancer. Ann. Intern. Med. 1993; 118: 785-90.
6. Shieh MJ, Wang CY,Wong JM, Lin YM, Sung JL. Colonoscopic screening for families of patients with colorectal cancer. J. Formos. Med. Assoc: 1996; 95: 828-32.
7. Wu CS, Tung SY, Chen PC, Kuo YC. The role of colonoscopy in screening persons with a family history of colorectal cancer. J. Gastroenterol. Hepatol. 1995; 10: 319-23.
8. Hunt LM, Rooney PS, Bostock K, Robinson MHE, Hardcastle JD, Armitage NC. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer. Gut 1997; 40: 110-12.
9. Winawer SJ, Fletcher RH, Miller L et al. Colorectal Cancer Screening: Clinical Guidelines and Rationale. Gastroenterology 1997; 112: 594-642.
10. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 1993; 328: 1365-71.
11. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult blood tests for colorectal cancer screening. N. Engl. J. Med. 1996; 334: 155-9.
12. Robinson MHE, Marks CG, Farrands PA, Thomas WM, Hardcastle JD. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br. J. Surg. 1994; 81: 448-51.
13. Wahrendorf J, Robra B, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening results from a population-based case-control evaluation in Saarland, Germany. Eur. J. Cancer Prev. 1993; 2: 221-7.
14. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer: A case-control study. Ann. Intern. Med. 1993; 118: 1-6.
15. Hiwatashi N, Morimoto T, Fukao A et al. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study. Jpn. J. Cancer Res. 1993; 84: 1110-12.
16. Saito H, Soma Y, Koeda J et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int. J. Cancer 1995; 61: 465-9.
17. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J. Natl Cancer Inst. 1993; 85: 1311-18.
18. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271: 1011-13.
19. Mandel JS, Church TR, Ederer F. Screening for colorectal cancer. N. Engl. J. Med. 1993; 329: 1353-4.
20. Olynyk JK, Aquilia S, Fletcher DR, Dickinson JA. Flexible sigmoidoscopy screening for colorectal cancer in average-risk subjects: a community-based pilot project. Med. J. Aust. 1996; 165: 74-6.
21. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening Sigmoidoscopy and Colorectal Cancer Mortality. J. Natl Cancer Inst. 1992; 84: 1572-5.
22. Selby JV,Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 1992; 326: 653-7.
23. Scharling ES, Wolfman NT, Bechtold RE. Computed tomography evaluation of colorectal carcinoma. Semin. Roentgenol. 1996; 31 (Suppl 2): 142-53.
24. Lieberman DA. Cost-effectiveness Model for Colon Cancer Screening. Gastroenterologey 1995; 109: 1781-90.
25. Wagner JL, Tunis S, Brown M et al. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996; 321-56.
26. Office of Technology Assessment, Congress of the United States. Cost-Effectiveness of Colorectal Cancer Screenings in Average-Risk Adults. Washington: April 1995.
27. Salkeld G, Young G, Irwig L, Haas M, Glasziou P. Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Aust. NZ J. Pub. Health 1996; 20: 138-43.
28. Shimbo T, Glick HA, Eisenberg JM. Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan. Int. J. Technol. Assess. Health Care 1994; 10 (Suppl 3): 359-75.
29. Gnauck R. Screening for Colon Cancer in Germany. Tumori 1995; 81 (Suppl): 30-7.